For example, diminished STAT6 phosphorylation results in downregulation of the T cell inhibitory molecule programmed death ligand 2 (PD-L2) on both DCs and tumor cells, which enhances tumor cell recognition by T cells [15, 18]. Here, PDCD1LG2 is linked to neoplasm.